108 related articles for article (PubMed ID: 14760099)
1. Influence of dosing schedule on toxicity and antitumor effects of a combination of adriamycin and docetaxel in mice.
To H; Shin M; Tabuchi M; Sakaguchi H; Takeuchi A; Matsunaga N; Higuchi S; Ohdo S
Clin Cancer Res; 2004 Jan; 10(2):762-9. PubMed ID: 14760099
[TBL] [Abstract][Full Text] [Related]
2. Pre-administration of docetaxel protects against adriamycin-induced cardiotoxicity.
Sakaguchi H; Kodama A; Tomonari M; Ando Y; Tabuchi M; To H; Araki R; Kitahara T; Sasaki H; Ohdo S; Higuchi S
Breast Cancer Res Treat; 2008 Jun; 109(3):443-50. PubMed ID: 17661173
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the cardioprotective effects of docetaxel pre-administration against adriamycin-induced cardiotoxicity.
Tomonari M; To H; Nishida M; Mishima T; Sasaki H; Kurose H
J Pharmacol Sci; 2011; 115(3):336-45. PubMed ID: 21358119
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic index by combination of adriamycin and docetaxel depends on dosing time in mice.
Tabuchi M; To H; Sakaguchi H; Goto N; Takeuchi A; Higuchi S; Ohdo S
Cancer Res; 2005 Sep; 65(18):8448-54. PubMed ID: 16166324
[TBL] [Abstract][Full Text] [Related]
5. A toxicoproteomic study on cardioprotective effects of pre-administration of docetaxel in a mouse model of adriamycin-induced cardiotoxicity.
Ohyama K; Tomonari M; Ichibangase T; To H; Kishikawa N; Nakashima K; Imai K; Kuroda N
Biochem Pharmacol; 2010 Aug; 80(4):540-7. PubMed ID: 20457137
[TBL] [Abstract][Full Text] [Related]
6. [Construction of optimal combined chemotherapy of anti-tumor drugs based on chronotherapy].
To H
Yakugaku Zasshi; 2006 Jun; 126(6):415-22. PubMed ID: 16755128
[TBL] [Abstract][Full Text] [Related]
7. Influence of dosing schedules on toxicity and antitumour effects of combined cisplatin and docetaxel treatment in mice.
Kodama A; To H; Kinoshita T; Ieiri I; Higuchi S
J Pharm Pharmacol; 2009 May; 61(5):615-21. PubMed ID: 19406000
[TBL] [Abstract][Full Text] [Related]
8. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination.
Granda TG; Filipski E; D'Attino RM; Vrignaud P; Anjo A; Bissery MC; Lévi F
Cancer Res; 2001 Mar; 61(5):1996-2001. PubMed ID: 11280758
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic/Pharmacodynamic Modeling of Schedule-Dependent Interaction between Docetaxel and Cabozantinib in Human Prostate Cancer Xenograft Models.
Chen W; Chen R; Li J; Fu Y; Yang L; Su H; Yao Y; Li L; Zhou T; Lu W
J Pharmacol Exp Ther; 2018 Jan; 364(1):13-25. PubMed ID: 29084815
[TBL] [Abstract][Full Text] [Related]
10. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice.
Asaumi J; Nishikawa K; Matsuoka H; Iwata M; Kawasaki S; Hiraki Y; Nishijima K
Anticancer Res; 1995; 15(1):67-70. PubMed ID: 7733643
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group.
von Minckwitz G; Raab G; Caputo A; Schütte M; Hilfrich J; Blohmer JU; Gerber B; Costa SD; Merkle E; Eidtmann H; Lampe D; Jackisch C; du Bois A; Kaufmann M
J Clin Oncol; 2005 Apr; 23(12):2676-85. PubMed ID: 15837982
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer.
Yin H; Guo R; Xu Y; Zheng Y; Hou Z; Dai X; Zhang Z; Zheng D; Xu H
Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):147-53. PubMed ID: 22126905
[TBL] [Abstract][Full Text] [Related]
13. Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer.
Itoh K; Sasaki Y; Fujii H; Minami H; Ohtsu T; Wakita H; Igarashi T; Watanabe Y; Onozawa Y; Kashimura M; Ohashi Y
Clin Cancer Res; 2000 Oct; 6(10):4082-90. PubMed ID: 11051260
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel in combination chemotherapy for metastatic breast cancer.
Khayat D; Antoine E
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery.
Zheng D; Li D; Lu X; Feng Z
Oncol Rep; 2010 Mar; 23(3):717-24. PubMed ID: 20127011
[TBL] [Abstract][Full Text] [Related]
16. Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer.
Ito Y; Aiba K; Horikoshi N; Saotome T; Irie T; Sugiyama K; Nakane M; Hashimoto D; Yoshida N; Mizunuma N; Takahashi S; Tanigawara Y
Int J Clin Oncol; 2001 Oct; 6(5):242-7. PubMed ID: 11723746
[TBL] [Abstract][Full Text] [Related]
17. Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice.
Naganuma A; Satoh M; Imura N
Jpn J Cancer Res; 1988 Mar; 79(3):406-11. PubMed ID: 3131288
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancer.
Puhalla S; Mrozek E; Young D; Ottman S; McVey A; Kendra K; Merriman NJ; Knapp M; Patel T; Thompson ME; Maher JF; Moore TD; Shapiro CL
J Clin Oncol; 2008 Apr; 26(10):1691-7. PubMed ID: 18316792
[TBL] [Abstract][Full Text] [Related]
19. Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients.
Hénin E; Meille C; Barbolosi D; You B; Guitton J; Iliadis A; Freyer G
Breast Cancer Res Treat; 2016 Apr; 156(2):331-41. PubMed ID: 27002506
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
Jones B; Komarnitsky P; Miller GT; Amedio J; Wallner BP
Anticancer Drugs; 2012 Feb; 23(2):173-84. PubMed ID: 22027537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
